Leave Your Message
Alpha Lipoic Acid/ ALA
Vitamin & derivatives

Alpha Lipoic Acid/ ALA

Alpha Lipoic Acid is slightly yellowcrystal powder or granular.In the body, alpha lipoic acid is a disulfide compound, which is an essential factor for the energy metabolism of human cells. lt is a unique anti-free radical substance, usually called abroad antioxidant.

  • CAS: 1077-28-7

C8H14O2S2

1

Description

α-Lipoic acid (ALA) is an endogenous powerful antioxidant with both water-soluble and fat-soluble properties, and is known as the "universal antioxidant". It has a small molecular weight and strong penetration, and can directly reach the cell mitochondria and whole body tissues. It shows multiple health values ​​in the fields of anti-aging, metabolic regulation, neuroprotection and anti-glycation, and has become a star ingredient in the field of modern nutritional supplements.

Core nutritional health care effects

Super strong antioxidant and anti-aging α-Lipoic acid directly removes reactive oxygen species (ROS) such as hydroxyl free radicals and peroxynitrite, and can regenerate antioxidants such as vitamin C, vitamin E and glutathione to form a synergistic defense network. Its antioxidant capacity is 400 times that of vitamin C/E. Its water-lipid dual-solubility allows it to penetrate deep into the dermis of the skin, reduce ultraviolet-induced collagen glycation (AGEs), improve wrinkles, spots and rough skin, and clinical topical use can increase skin brightness by more than 30%.

Metabolic support and blood sugar regulation

As a coenzyme of pyruvate dehydrogenase, α-lipoic acid promotes the conversion of glucose into energy, enhances insulin sensitivity, and reduces insulin resistance. Studies have shown that daily supplementation of 600 mg can increase the nerve conduction velocity of diabetic patients (an average increase of 4.5 m/s) and significantly relieve the pain and numbness of peripheral neuropathy. At the same time, it reduces endothelial oxidative damage and reduces the risk of atherosclerosis by inhibiting the NF-κB inflammatory pathway.

Nervous system protection and cognitive enhancement

α-lipoic acid can penetrate the blood-brain barrier, reduce the toxicity of β-amyloid protein (Aβ) deposition on neurons, and delay the progression of Alzheimer's disease; by chelating excess iron ions, it inhibits oxidative stress and improves Parkinson's disease symptoms. Clinical trials have shown that long-term supplementation can improve memory and attention and reduce the risk of cognitive decline.

Liver detoxification and heavy metal chelation

As a natural metal chelator, α-lipoic acid can bind to toxic heavy metals such as lead, mercury, and cadmium, accelerate their excretion from the body, and reduce the burden on the liver. It has a clearing effect on fat accumulation in non-alcoholic fatty liver disease and reduces liver inflammation indicators (such as ALT, AST).

Weight management and anti-glycation

Alpha-lipoic acid activates the AMPK signaling pathway, promotes fat oxidation metabolism, and reduces visceral fat accumulation. Studies have shown that overweight people supplement 600 mg daily, and their body fat rate drops by an average of 5.2% after 24 weeks. At the same time, it inhibits the binding of sugar to collagen, reduces skin glycation damage, and maintains skin elasticity.

Product advantages and recommended solutions

High bioavailability: Using nano-microcapsule technology, the oral absorption rate is 40% higher than that of traditional dosage forms, and the blood drug concentration is more stable.

Safety guarantee: The clinical dose of 300-600 mg/day is well tolerated, has no cumulative toxicity, and long-term use has rare side effects.

Multi-scenario application: supports tablets, capsules, topical creams and intravenous injections to meet daily health care and medical needs.

Recommended population:
Diabetic patients and those at risk of high blood sugar;
Sub-healthy groups who need antioxidant and anti-aging;
People who have long-term exposure to heavy metals or environmental pollution;
Patients with cognitive impairment and neurodegenerative diseases.